Double-blind, placebo-controlled assessment of potential interactions between intravenous methamphetamine and osmotic-release methylphenidate (OROS-MPH)

Trial Profile

Double-blind, placebo-controlled assessment of potential interactions between intravenous methamphetamine and osmotic-release methylphenidate (OROS-MPH)

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Mar 2009

At a glance

  • Drugs Metamfetamine (Primary) ; Methylphenidate (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 16 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top